Intensity‐modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial is a research paper published in Cancer (2021). On theSindex it has a DataRank of 0.863. It has been cited 27 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.500
From this paper's citation signal
Citation Network Contribution
0.363
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
NCI NIH HHS
Grant: K12 CA184746
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 5K12CA184746-02
MSK Paul Calabresi Career Development Award for Clinical Oncology
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
FWCI
1.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals